Cisplatin is a common, powerful chemotherapy agent used for a wide range of cancers such as breast, ovarian and lung, that in a handful of days can also permanently damage or destroy patients' kidneys ...

Chemotherapy and radiation are common treatments for lung cancer. However, immunotherapy may be able to help double a patient's survival, according to a new report. Researchers from New York ...

Squamous cell carcinoma of the lung is linked to smoking and requires early detection and accurate staging for effective treatment. Diagnosis involves imaging and biopsy, with the TNM system used to ...

Combining osimertinib with chemotherapy significantly improved overall survival in advanced EGFR-mutated non-small cell lung cancer. The FLAURA2 trial showed a consistent survival benefit and extended ...

Adding immunotherapy to chemotherapy before surgery for patients with operable non-small cell lung cancer—the leading cause of cancer deaths worldwide—improved long-term survival overall compared with ...

Trilaciclib significantly reduced chemotherapy-induced myelosuppression in extensive-stage small cell lung cancer, which authors say minimizes the need for supportive care. Administered before ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...

Liv Hospital, the pioneer provider of personalized care, relies on the principle that each patient's cancer is different. The team undertakes to target the specific causes of a person's cancer rather ...